AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01494519 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery with an external ring fixator
Description: Modern ring external fixator is defined as any fixator that has at least 1 ring proximal and 1 ring distal to the fracture site. The rings may be connected to the tibia using any combination of external fixation pins or wires at the surgeon's discretion. There must be at least two pins or wires connected to each ring, and typically there will be at least three pins or wires. Any FDA approved ring fixator meeting this definition from any manufacturer is allowed.
Study NCT01494519 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Definitive fixation with a locked IM nail or plate
Description: Eligible patients with tibial diaphyseal fractures will typically receive a standard locked IM Nail. The nail must use at least one static interlock proximal to and one static interlock distal to the fracture site. The nail may be placed with either a reamed or unreamed technique.~Methaphyseal fractures, especially those with fracture lines extending into the joint may be more commonly treated with plate fixation. The plate may be applied in an open or percutaneous fashion. Any combination of locked and/or non-locked screws may be used.
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine 6 mcg
Description: An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine 10 mcg
Description: An intravenous bolus of norepinephrine 10 mcg will be administered for management of maternal hypotension.
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: Subarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: Subarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg
Study NCT02070705 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Description: Undergo DCE MRI
Study NCT02070705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Description: Given IV
Study NCT02070705 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferumoxytol
Description: Given IV
Study NCT01212666 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ropivacain
Description: Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose.
Study NCT01212666 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose.
Study NCT00496145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spanish Diabetes Self-Management Program
Description: small-group self management education program
Study NCT01871116 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: POWER-remote
Description: Web-based weight loss program.
Study NCT01871116 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-directed
Description: Pamphlet entitled Aim for a Healthy Weight will be given.
Study NCT00430560 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive rehabilitation
Description: computer training
Study NCT00430560 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: work therapy
Description: opportunity to work in carefully supervised hospital job
Study NCT00430560 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: work therapy
Description: work therapy
Study NCT01916356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: educational video
Description: Educational video covering topics of basic reproductive biology, infertility etiologies, risk factors, treatments and common myths.
Study NCT04244188 — intervention group
Intervention type: OTHER
Intervention: Collection of datas
Description: Collection of datas: pre- and postoperative scanner and endoprosthesis characteristics
Study NCT02865993 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: betadine group
Description: Patients intra-operatively received intraperitoneal irrigation prior to abdominal closure with low molecular weight povidone-iodine solution ('Betadine LMW') (PVP-I LMW) diluted 50:50 with normal saline.
Study NCT02865993 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no betadine group
Description: Patients intra-operatively received intraperitoneal irrigation prior to abdominal closure with only normal saline solution.
Study NCT03051321 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wellness toilet system
Description: Water-based toileting with capacity to apply zinc oxide barrier spray to treat incontinence associated dermatitis
Study NCT01237535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luteal support with progesterone only
Description: Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel).Luteal support will begin after insemination and will be continued through the 12th week of gestation if the patient conceived.If no pregnancy will be achieved patients will undergo 3 treatment cycles preferably in the same treatment group.
Study NCT01237535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luteal support with estrogen + progesterone
Description: Luteal support with estrogen + progesterone \[(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg\].Luteal support will begin after insemination and will be continued through the 12th week of gestation if the patient conceived.If no pregnancy will be achieved patients will undergo 3 treatment cycles preferably in the same treatment group.
Study NCT01668394 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Learning and coping arm
Description: Participation of experienced patients as co-educators. Completion of two individual clarifying interviews. Teaching style: situated, reflective, inductive.
Study NCT01668394 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control arm
Description: Usual care. Teaching style: deductive.
Study NCT01237535 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Insemination without luteal support
Description: Routine insemination procedure without luteal support
Study NCT02788968 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Description: Conventional reasoning tasks in both  with and without cognitive conflict and realized during an MRI
Study NCT02788968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI
Description: Conventional reasoning tasks in both  with and without cognitive conflict and realized during an MRI
Study NCT04011501 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Continuous Erector spinae block
Description: Erector spine block and catheter placement will be performed for continuous analgesia prior to the surgical procedure.A initial bolus of 20 ml of Levobupivacaine 0.25% will be administered. Subsequently a 22G catheter will be introduced. At the end of the surgery, an elastomeric pump will be installed at a flow rate of 7 ml / hr with a 1.3% Ropivacaine solution.
Study NCT00937872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 250 mg SRT2104 Suspension
Description: Single 10 mL oral dose of 250 mg SRT2104 delivered as a suspension formulation.
Study NCT00937872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbon-14 radio-labeled SRT2104
Description: Single 10 mL IV dose containing 100 microgram (not more than 250 nCi, 9.25 kBq) Carbon-14 radio-labeled SRT2104, administered by IV infusion over 15 minutes, starting 2 hours and 45 minutes after the oral dose is administered.
Study NCT01825382 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iBGStar meter
Description: Subjects will receive iBGStar meter and iPhone to use as meter during the study.
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine infusion
Description: Prophylactic norepinephrine infusion will be started after subarachnoid block
Study NCT03712111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion
Description: Prophylactic norepinephrine infusion will be started after subarachnoid block
Study NCT02858557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Description: The Mediterranean diet is rich in complex carbohydrates and fibers and low in animal proteins and fats.
Study NCT01185119 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: native glp-1 (7-36)
Description: During hyperglycemic clamp and GLP-1 versus placebo infusion 10 men will be CNS-PET scanned
Study NCT01185119 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: native glp-1 (7-36)
Description: During hyperglycemic clamp and GLP-1 versus placebo infusion 10 men will be CNS-PET scanned
Study NCT02858557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet
Description: The specific carbohydrate diet is a dietary program popular among patients with IBD. The diet allows carbohydrate foods consisting of mono-saccharides only, and excludes di-saccharides and most polysaccharides.
Study NCT03713541 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Survey during normal supply.
Study NCT01763294 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nicolet Endeavor CR: 30min
Description: Transcranial direct current stimulation (tDCS) is a safe, non-invasive method that modulates cortical excitability. In direct current polarization, the cerebral cortex is stimulated through a weak constant electric current in a noninvasive and painless manner. This weak current induces focal changes of cortical excitability increase or decrease depending on the electrode polarity- that last beyond the period of stimulation.
Study NCT01763294 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nicolet Endeavor CR: 60min
Description: Transcranial direct current stimulation (tDCS) is a safe, non-invasive method that modulates cortical excitability. In direct current polarization, the cerebral cortex is stimulated through a weak constant electric current in a noninvasive and painless manner. This weak current induces focal changes of cortical excitability increase or decrease depending on the electrode polarity- that last beyond the period of stimulation.
Study NCT01763294 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nicolet Endeavor CR: 30min for 3 days
Description: Transcranial direct current stimulation (tDCS) is a safe, non-invasive method that modulates cortical excitability. In direct current polarization, the cerebral cortex is stimulated through a weak constant electric current in a noninvasive and painless manner. This weak current induces focal changes of cortical excitability increase or decrease depending on the electrode polarity- that last beyond the period of stimulation.
Study NCT01763294 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nicolet Endeavor CR: 30min for 5 days
Description: Transcranial direct current stimulation (tDCS) is a safe, non-invasive method that modulates cortical excitability. In direct current polarization, the cerebral cortex is stimulated through a weak constant electric current in a noninvasive and painless manner. This weak current induces focal changes of cortical excitability increase or decrease depending on the electrode polarity- that last beyond the period of stimulation.
Study NCT01763294 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nicolet Endeavor CR: Placebo
Description: The same procedures just that in this case the machine produces only a 60 second stimulus at the beginning so the patient can feel the initial electric stimulus.
Study NCT01569386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily low intensity physical activity by the half squat
Description: They take a meal three times daily. They are a time to do the manual work every day. They watch the TV for two hours every day. And they do a walk of 30 minutes every day. They do a specific exercise. They were trained to conduct 40kcal period(about 20 min.) for adding to the amount of energy consumption of low-intensity physical activity at baseline.Specific exercise that was done the half squat(max knee flexion 70 degree). This squat is carried out in two seconds round trip. This squat is carried out in two seconds round trip. They grab the edge of the table. They put half the weight of the lower limbs paralyzed side. This observer once a week, to record their behavior over 24 hours. Intervention period is up to a maximum of 12 weeks.
Study NCT01569386 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: stretch exercise and usual activity
Description: They take a meal three times daily.They are a time to do the manual work every day.They watch the TV for two hours every day.And they do a walk of 30 minutes every day.They do whole body stretch exercise for 20 minute in a day. An observer once a week, to record their behavior over 24 hours.Their behavior was used to calculate the amount of energy consumption.They are informed of the kcal a day from the viewer.
Study NCT01329744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mecasermin
Description: a subcutaneous injection twice a day
Study NCT01329744 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo control
Description: Subcutaneous injection given twice per day of placebo compound, for 24 weeks
Study NCT03569839 — intervention group
Intervention type: DRUG
Intervention: Propofol
Description: Patients undergoing surgery, TIVA (total intravenous anaesthesia)
Study NCT01123824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CLOPIDOGREL
Description: Pharmaceutical form: tablets~Route of administration: oral
Study NCT01123824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: Pharmaceutical form: matching tablets~Route of administration: oral
Study NCT03553082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Fentanyl 2 µg/kg for induction of anesthesia and sevoflurane 2% for maintenance
Study NCT03305328 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Alternating Current Stimulation
Description: Transcranial Alternating Current Stimulation passes a weak, 2 mA sinusoidal current through the scalp to the cortex at a specified frequency. Previous evidence suggests this exogenous sinusoidal stimulation interacts with the endogenous, cortical sinusoidal oscillatory activity, resulting in modulations of cortical oscillations. The intervention is non-invasive and virtually painless with no lasting adverse side-effects.
Study NCT03553082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol 5-6 mg/kg and fentanyl 2 µg/kg for induction of anesthesia and propofol 250-300 µg/kg/min for maintenance
Study NCT03695965 — intervention group
Intervention type: PROCEDURE
Intervention: magnetic resonance imaging.
Description: 1.5 Tesla magnet system is going to be utilized for ankle imaging. A dedicated extremity surface coil (Foot/Ankle 16-Channel Coil; Siemens Medical Solution) is used to enhance spatial resolution.
Study NCT04059107 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Printed Myoelectric Prosthetic Device
Description: 3D Printed Myoelectric Prosthetic Device
Study NCT02963701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Fixed dose combination
Study NCT02963701 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Fixed dose combination
Study NCT02963701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine-HCl
Description: Fixed dose combination
Study NCT02963701 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pseudoephedrine-HCl
Description: Fixed dose combination
Study NCT01954316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFI-400945
Description: Polo-like kinase 4 (PLK4) inhibitor
Study NCT04119102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duobrii
Description: duobrii applied daily for 4 weeks followed by every other day for 4 weeks.
Study NCT02998034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Uncemented Furlong Hemiarthroplasty
Description: A furlong uncemeneted hyroxyapatite coated prosthesis.The hydroxyapatite stimulates bone ingrowth around the prosthesis and is this is thought to reduce loosening of the implant, residual pain and the long-term revision rate.
Study NCT02998034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cemented tapered stem hemiarthroplasty
Description: A cemented double tapered stem hemiarthroplasty
Study NCT03668834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dermabrasion with NCES
Description: 1. The recipient site will be shaved, cleaned with betadine and surgical spirit and anaesthetized with mixture of 2% lignocaine and NS (1:1).~2. Dermabrasion will be done using Manekshaw's dermabrader until tiny pinpoint bleeding spots are seen and extended 5mm beyond margins to prevent halo phenomenon.~3. The denuded area will be washed with PBS and covered with a PBS moistened gauze piece.~4. With 18 G needle attached to tuberculine syringe, few small drops of non cultured epidermal cell suspension will be placed over the denuded surface and spread evenly.~5. Dressing is done in 4 layers in order-collagen(Neuskin F), bactigras, cutisoft(sterile gauze) and dynaplast (elastic plaster).
Study NCT03668834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dermaroller with NCES
Description: 1. The recipient site will be shaved, cleaned with betadine and surgical spirit.~2. Microneedling will be done with a device containing 540 microneedles in 8 rows, each 0.25 mm in length. Microneedling will be extended 5 mm beyond margins to prevent halo phenomenon.~3. The roller will be passed repeatedly over the skin in a star-shaped way for about 10 minutes~4. The noncultured epidermal cell suspension will be carefully transferred to a tuberculin syringe.~5. NCES will be applied to the skin surface with a tuberculin syringe with an 18G needle and spread evenly after dermarolling treatment.~6. Dressing is done in 4 layers in order-collagen(Neuskin F), bactigras, cutisoft(sterile gauze) and dynaplast (elastic plaster).
Study NCT03668834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Liquid nitrogen induced blister with NCES
Description: 1. The recipient site will be shaved, cleaned with betadine and surgical spirit and anaesthetized with mixture of 2% lignocaine and NS (1:1).~2. The site to be grafted is outlined with a surgical marking pen.~3. To induce blisters on the achromic areas, freezing with liquid nitrogen spray was performed during 10 to 20 seconds inside round circles previously drawn on the skin.~4. The patient is asked to visit 24 hours later.~5. The blister fluid is aspirated and NCES taken in tuberculin syringe with 18 G needle is injected into it such that the blister roof is preserved.~6. Dressing is done in 4 layers in order-collagen(Neuskin F), bactigras, cutisoft(sterile gauze) and dynaplast (elastic plaster).
Study NCT00911573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tigecycline
Description: 50 mg IV every 12 hours up to 14 days
Study NCT00911573 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clindamycin (or Vancomycin if needed)
Description: For clindamycin 10mg/kg (not to exceed 900mg) IV every 8 hours up to 14 days. For vancomycin 15mg/kg (not to exceed 2g/day and adjusted as needed for renal impairment) IV every 8 hours
Study NCT04057885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Orthosensor™ VERASENSE™ Knee System
Description: A group of patients will receive a total knee arthroplasty using the Orthosensor device
Study NCT04057885 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orthosensor™ VERASENSE™ Knee System
Description: A group of patients will receive a total knee arthroplasty using the Orthosensor device
Study NCT01508260 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aquapheresis
Description: Participant connected to aquapheresis pump through an intravenous (IV) catheter placed in forearm. Average treatment is about 24 hours but can extend up to 7 days.
Study NCT01508260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Furosemide
Description: 20-40 mg by vein every 8 hours as indicated for optimal diuresis to achieve negative fluid balance or 0.5 to 5 mg per hour by continuous infusion.
Study NCT00324233 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent catheter
Description: SpeediCath catherter (SC) for intermittent catherisation
Study NCT00324233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compact intermittent catheter
Description: SpeediCath Compact Male catheter (SCCM) is a compact intermittent catheter for males
Study NCT03334383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sponge
Description: Compressed cellulose sponge for use in laparoscopic surgery to retract the intestines from the surgical field.
Study NCT03963102 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ameluz
Description: Leaving on the gel for 4 hours rather than the standard 3 hours.
Study NCT03963102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ameluz
Description: Leaving on the gel for 4 hours rather than the standard 3 hours.